Blog

Orphan drugs: about as niche as a flat white

To those beyond the world of biopharma, the term “orphan drug” sounds a bit sad, a bit forgotten. But to those involved in the industry, the superior return on investment, supportive regulatory environment and rates of growth mean that these orphans are anything but tragic.